Series
ELSIconversations Series 1 - Winter/Spring 2021
A Qualitative Study to Develop a Privacy and Nondiscrimination Best Practice Framework for Personalized Wellness Programs

Rachele Hendricks-Sturrup, DHSc, MSc, MA - Harvard Pilgrim Health Care Institute and Harvard Medical School

ELSIconversations - February 26, 2021

Employers are increasingly partnering with direct-to-consumer (DTC) genetic testing companies and other unregulated companies that generate, collect, and process sensitive health information to offer personalized wellness products as a workplace wellness benefit. Countering claims about the benefits of these programs are concerns about employee health privacy and discrimination based on health factors or status. These concerns are legally grounded in the fact that 1) employers and DTC genetic testing companies are not covered under the Health Insurance Portability and Accountability Act, and 2) the United States (US) Supreme Court, in AARP v. EEOC, rejected regulations around wellness program incentive limits under the Genetic Information Nondiscrimination Act and Americans with Disabilities Act. This study qualitatively explored the concerns of public and legislative stakeholders to determine themes and best practices to overcome those concerns. Qualitative analysis was performed using NVivo software. A second coder was used to assess interrater reliability. Key themes centered on promoting a culture of trust and wellness. Best policy practices within these themes were : 1) have transparent and prominent data standards and practices, 2) uphold employee privacy and nondiscrimination standards, 3) remove penalties, 4) reward healthy behavior, and 5) make program benefits accessible. Employers, DTC genetic testing companies, and policymakers should consider these themes and best practices in the current absence of federal regulations on nondiscriminatory workplace wellness programs.

Tags

Keywords
Direct to Consumer Genetic Testing
direct to consumer marketing
Wellness programs

Videos in Series

ELSIconversations Series 1 - Winter/Spring 2021 - Platform Heals? Ethical Issues in Direct-to-consumer Telepharmacies

ELSIconversations Series 1 - Winter/Spring 2021 - Racial and Ethnic Classification in the Clinic: Is it Just?

ELSIconversations Series 1 - Winter/Spring 2021 - Defining the Critical Components of Informed Consent for Genetic Testing

ELSIconversations Series 1 - Winter/Spring 2021 - Human Germline Genome Editing and the Identity Politics of Genetic Disability